Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics
Most ATTRv amyloidosis cases in Israel are attributable to the Ser77Tyr variant. However, other variants also contribute to disease occurrence, and testing is warranted in clinically suspected patients.
Authors
- Arthur Pollak (ORCID: https://orcid.org/0000-0001-8628-1111)
- Efrat Shavit‐Stein (ORCID: https://orcid.org/0000-0003-3373-8397)
- Rivka Goldis
- Daniela Gonsalves Shapiro
- Elon Pras (ORCID: https://orcid.org/0000-0001-8094-7429)
- Osnat Itzhaki Ben Zadok
- Michael Arad (ORCID: https://orcid.org/0000-0003-3723-7493)
- Dana Fourey
- Tayir Alon
- Haike Reznik‐Wolf
- Batia Kaplan (ORCID: https://orcid.org/0000-0003-1486-681X)
- Avi Fellner (ORCID: https://orcid.org/0000-0001-5354-9134)
- Amir Dori (ORCID: https://orcid.org/0000-0003-4633-1481)
- Ortal Barel (ORCID: https://orcid.org/0000-0003-1168-9758)
- Odelia Chorin (ORCID: https://orcid.org/0000-0001-8968-0732)
- Lior Greenbaum (ORCID: https://orcid.org/0000-0001-6176-0941)
- Merav Ben‐David (ORCID: https://orcid.org/0000-0001-8617-4156)
- Yaron Aviv (ORCID: https://orcid.org/0000-0002-8158-6802)
- Noa Ruhrman‐Shahar (ORCID: https://orcid.org/0009-0009-8725-2596)
- Vardiella Meiner (ORCID: https://orcid.org/0000-0001-6284-9657)
- Vera Nikitin
Institutions
- Rafael Advanced Defense Systems (Israel) (IL)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Sheba Medical Center (IL)
- Hadassah Medical Center (IL)
- Rabin Medical Center (IL)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1111/ene.70057
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Pfizer